BIOSANTECH SA ® | Recherche et développement, France


OMICS International is going to organize its Retroviruses-2015 in media collaboration with BIOSANTECH, USA during June 08-09, 2015 in Chicago, USA. We intend our scientists to work alongside taking the advantage of our world-class facilities, to push the boundaries of retroviral research.
BIOSANTECH has an exclusive cooperation agreement with the CNRS and the University of Aix-Marseille and owns the exclusive license for the use and commercialization of patents CNRS concerning TAT oyi. BIOSANTECH, has so far the most advanced in the world have been allowed to enter Phase II III necessary for its therapeutic vaccine marketing . The results demonstrate the effectiveness of the vaccine in patients infected with AIDS in progress. It is the Sponsor for our event helping us to reach more audience. Omics International welcomes you to the International Conference on Retroviruses and Novel Drugs to be held from June 8-09, 2015 in Chicago, USA. The theme of Retroviruses-2015 is “Current Concepts In Retroviruses & Advanced Drug.” Omics International organizes 1000+ Global events every year across the globe with support from 1000+ more scientific societies and Publishes 500 Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members. The conference expects the participation of experts from various cross disciplines like virologists, immunologists, microbiologists, epidemiologists, doctors, public health planners, pharmacologists, computational biologists, and those in applied fields conducting influenza related research.